Memorial Şişli Hospital
The average price for Complex treatment of neuroblastoma in Turkey typically ranges from $28,000 to $42,000. This cost varies depending on the specific protocol, tumor stage, and required diagnostic depth. Internationally, similar treatments in the US average around $150,000, allowing for savings of approximately 77%. Standard packages usually include specialized oncology consultations, chemotherapy cycles, surgery, and stays in JCI-accredited facilities.
Bookimed Expert Insight: Choosing a multi-specialty center like Medipol Mega University Hospital provides access to high-volume bone marrow transplant units. Medipol features one of the largest units in Turkey and utilizes the Da Vinci Surgical System. For families seeking specialized care, Memorial Şişli offers a 90% organ transplant success rate. This indicates high surgical proficiency essential for complex neuroblastoma resections. Selecting JCI-accredited clinics ensures international safety standards at approximately $34,100 to $40,000 for comprehensive programs.
Why do patients choose Turkey for the complex treatment of neuroblastoma?
Access advanced Complex treatment of neuroblastoma solutions in trusted clinics .
| Turkey | Austria | Spain | |
| Complex treatment of neuroblastoma | from $28,000 | from $180,000 | from $70,000 |
Day 1
Day 2
Day 3
Day 4
Day 5
Day 6-14
Week 2-4
Week 4-8
Please note that each case is unique and the above timeline is an estimate. Your healthcare team will provide a personalized treatment plan.
75+ international publications in pediatric oncology – Dr. Apak leads the Pediatric Hematology-Oncology Division at Istanbul University-Cerrahpaşa with 26 years of experience of specialized experience.
Prof. Metin Demirkaya specializes in pediatric oncology, with extensive training and experience in neuroblastoma treatment at Medicana Bursa Hospital.
Neuroblastoma treatment in Turkey follows a risk-adapted multimodal approach combining surgery, chemotherapy, and advanced biological therapies. Protocols are standardized by the Turkish Pediatric Oncology Group (TPOG) and the Children's Oncology Group (COG). High-risk cases often involve autologous stem cell transplantation and targeted MIBG therapy in JCI-accredited facilities.
Bookimed Expert Insight: Turkish oncology centers offer a significant efficiency advantage for international families. While European programs often have strict intake windows, private institutions like Memorial Şişli provide immediate access to TPOG 2020 protocols. These centers maintain 90% success rates for complex pediatric transplants, matching American standards at a fraction of the cost.
Patient Consensus: Parents emphasize that early risk stratification via MYCN testing was vital for choosing between observation and aggressive surgery. Many noted that post-treatment MIBG scans provided essential peace of mind for monitoring potential relapses.
Turkish hospitals such as Memorial Şişli, Medipol Mega, and Hisar Intercontinental are leading centers for neuroblastoma treatment. These JCI-accredited facilities provide advanced pediatric oncology care, including autologous stem cell transplants, immunotherapy, and targeted radiotherapy, often at costs 77% lower than US averages.
Bookimed Expert Insight: While many families focus on hospital brands, the real differentiator in Turkey is the volume of bone marrow transplants performed. Medipol Mega and Emsey Hospital manage significantly higher pediatric bed capacities than many European centers. This high volume often translates to more refined nursing protocols for managing post-transplant complications in children.
Patient Consensus: Families often emphasize the importance of requesting specific international protocols like SIOPEN. They recommend securing a second opinion from European experts before finalizing the surgical approach in Istanbul.
Parents should ask about their child's specific risk group, MYCN gene status, and the multi-phase treatment plan. Essential queries include the integration of high-intensity chemotherapy, surgery, and immunotherapy. Confirm if the clinic follows international COG or SIOP protocols to ensure standardized, high-quality pediatric oncological care.
Bookimed Expert Insight: While many search for the lowest price, the real value in Turkey lies in multidisciplinary tumor boards. Clinics like Memorial Şişli Hospital or Medipol Mega utilize 400+ specialists to review complex cases. This collaborative approach often mirrors top US centers but at 77% lower costs. Always verify if your surgeon works specifically within a dedicated pediatric oncology department rather than a general surgical unit.
Patient Consensus: Families emphasize the importance of requesting written treatment protocols and independent pathology reviews early on. They recommend confirming long-term survivorship plans, including cardiac and endocrine monitoring, before the first cycle of chemotherapy begins.
Families should plan for a 6-week to 6-month stay in Turkey for intensive neuroblastoma treatment phases. While initial diagnostics take 2–4 days, complex protocols involving surgery, chemotherapy, and stem cell transplants often require 4–7 months of local residency for monitoring.
Bookimed Expert Insight: Data from top-tier centers like Memorial Şişli and Medipol show that stay durations vary by infrastructure. Medipol features a massive 810-bed capacity, often streamlining the transition between chemotherapy and surgery. Families can often reduce total time by coordinating the 5-day chemotherapy hospitalizations with local outpatient housing.
Patient Consensus: Most families recommend budgeting 4–6 months minimum to account for recovery buffers. They suggest extending tourist visas early to avoid stress during intensive 6-week transplant isolation periods.
Turkish clinics provide comprehensive support for international paediatric cancer patients through dedicated international patient departments. These centres manage logistics for complex neuroblastoma treatments. They offer medical interpreters, airport transfers, and help with long-term family accommodation. This is available in cities like Istanbul and Antalya.
Bookimed Expert Insight: While many centres offer support, Memorial Antalya Hospital stands out. It provides a dedicated 5-star guest house specifically for international families. This is a significant benefit for neuroblastoma cases. They often need multi-week stays for radiotherapy or stem cell transplants.
Patient Consensus: Families find that large hospital groups in Turkey offer well-organised pathways with helpful translators. Established oncology centres provide the necessary aftercare and stable support systems. These are needed for sensitive paediatric treatments.
Turkey hosts JCI-accredited facilities specialising in paediatric oncology and complex neuroblastoma care. Leading centres include Memorial Şişli Hospital, Medipol Mega University Hospital, and Hisar Hospital Intercontinental. These hospitals provide multidisciplinary teams and TrueBeam STx radiotherapy. They also have bone marrow transplant units required for high-risk childhood tumours.
Bookimed Expert Insight: Turkish oncology centres like Memorial Antalya follow strict NCCN and ESMO international guidelines. While basic chemotherapy is common, these major hubs offer rare specialisations. Dr Hilmi Apak at Biruni University Hospital, for example, specialises in haploidentical stem cell transplantation. He also offers CAR T-cell therapy.
Patient Consensus: Large tertiary centres in Turkey are highly praised for managing rare childhood cancers. Families highlight the coordinated care between oncology and surgery. The experience of doctors in major Istanbul hospitals provides immense confidence during complex treatment.
High-risk neuroblastoma survival rates in Turkey have improved significantly. Contemporary specialised centres report 5-year overall survival between 50% and 68%. University hospitals utilise intensive multimodal protocols. These protocols include immunotherapy and stem cell transplantation. They aim to align outcomes with international benchmarks for paediatric oncology care.
Bookimed Expert Insight: Turkish oncology centres offer a massive cost advantage for complex cases. Neuroblastoma treatment starts at $28,000. The A$662,400 Australian average is often prohibitive for uninsured families. However, Medipol Mega University Hospital provides the same multimodal care—surgery, radiotherapy, and stem cell transplant. This comes at a 7793% saving.
Patient Consensus: Success in Turkey relies on finishing the full protocol of chemotherapy, surgery, and immunotherapy. Families appreciate the speed of access and high-quality private hospital care during aggressive treatment cycles.
Neuroblastoma treatment in Turkey uses multi-modal, risk-adapted protocols. These include intensive chemotherapy, surgical resection, and high-dose chemotherapy with autologous stem cell transplantation. Leading JCI-accredited centres like Memorial Şişli and Medipol Mega also provide maintenance therapies. These include anti-GD2 immunotherapy and targeted radiation.
Bookimed Expert Insight: Turkish oncology centres like Medipol Mega often offer haploidentical stem cell transplants. These allow parents to act as donors when a perfect match is unavailable. This capability, combined with all-inclusive pricing from $28,000, makes Turkey a major hub for complex cases. These cases require immediate intervention without donor waitlists.
Patient Consensus: Treatment for high-risk neuroblastoma in Turkey involves a coordinated sequence of surgery, chemotherapy, and immunotherapy rather than a single procedure. Families appreciate having a personal coordinator to help manage these multiple stages and ensure smooth follow-up monitoring after they return home.
Turkish paediatric oncology centres perform comprehensive staging. This includes biopsy, PET-CT or MRI imaging, MIBG scintigraphy, and molecular profiling. These evaluations adhere to TPOG and COG guidelines to map tumour biology and metastatic spread. Specialists use these results to plan risk-adapted therapy before starting complex neuroblastoma treatment.
Bookimed Expert Insight: Turkish centres like Hisar Hospital Intercontinental use 640-slice CT scanners and PET-CT that detect 1-millimetre tumours. This precision is vital for neuroblastoma. Identifying tiny metastatic sites early can significantly change the staging and treatment plan. Centres often bundle these scans into initial diagnostic packages.
Patient Consensus: Diagnostic evaluation is a full staging process rather than a single test. Families found that private Istanbul hospitals coordinate oncology, radiology, and nuclear medicine in one location. This leads to faster results.